PR Newswire03.04.20
Tivic Health Systems Inc., announced ClearUP Sinus Pain Relief, a small handheld device that delivers a proprietary microcurrent waveform, has received CE mark approval for temporary relief of sinus pain, pressure and congestion, under the brand name ClearUP Sinus Relief. The combination of the company's FDA Clearance and CE mark approval opens the market for ClearUP to sell in over 190 countries.
Tivic Health will evaluate opportunities for international expansion through direct sales, partnerships, and retail distribution to establish a presence in overseas markets in 2021. ClearUP is part of a wave of new non-invasive neuromodulation devices coming to market that provide safe, non-drug options for patients with a variety of medical conditions.
"We have had overwhelming interest both from customers and distributors in international markets," said Jennifer Ernst, CEO of Tivic Health. "With the worldwide growth in sinus and allergy diseases, we look forward to forming strong partnerships to launch ClearUP internationally. For decades, the medical community has focused on treating conditions almost exclusively with chemical and drug therapies. We now see a growing number of companies exploring bioelectronic medicine – replacing drugs with targeted electrical stimulation. I am excited to be delivering one of the first non-prescription bioelectronic solutions to mainstream markets."
Tivic Health will evaluate opportunities for international expansion through direct sales, partnerships, and retail distribution to establish a presence in overseas markets in 2021. ClearUP is part of a wave of new non-invasive neuromodulation devices coming to market that provide safe, non-drug options for patients with a variety of medical conditions.
"We have had overwhelming interest both from customers and distributors in international markets," said Jennifer Ernst, CEO of Tivic Health. "With the worldwide growth in sinus and allergy diseases, we look forward to forming strong partnerships to launch ClearUP internationally. For decades, the medical community has focused on treating conditions almost exclusively with chemical and drug therapies. We now see a growing number of companies exploring bioelectronic medicine – replacing drugs with targeted electrical stimulation. I am excited to be delivering one of the first non-prescription bioelectronic solutions to mainstream markets."